143 related articles for article (PubMed ID: 19026704)
21. An Important Role for CD4
Tussiwand R; Behnke MS; Kretzer NM; Grajales-Reyes GE; Murphy TL; Schreiber RD; Murphy KM; Sibley LD
mSphere; 2020 Jul; 5(4):. PubMed ID: 32669460
[TBL] [Abstract][Full Text] [Related]
22. Fas-FasL interaction involved in pathogenesis of ocular toxoplasmosis in mice.
Hu MS; Schwartzman JD; Yeaman GR; Collins J; Seguin R; Khan IA; Kasper LH
Infect Immun; 1999 Feb; 67(2):928-35. PubMed ID: 9916110
[TBL] [Abstract][Full Text] [Related]
23. Protective immunity induced by a DNA vaccine expressing eIF4A of Toxoplasma gondii against acute toxoplasmosis in mice.
Chen J; Huang SY; Li ZY; Yuan ZG; Zhou DH; Petersen E; Zhang NZ; Zhu XQ
Vaccine; 2013 Mar; 31(13):1734-9. PubMed ID: 23370151
[TBL] [Abstract][Full Text] [Related]
24. Inducible nitric oxide synthase is not required for long-term vaccine-based immunity against Toxoplasma gondii.
Khan IA; Matsuura T; Kasper LH
J Immunol; 1998 Sep; 161(6):2994-3000. PubMed ID: 9743363
[TBL] [Abstract][Full Text] [Related]
25. A Toxoplasma gondii vaccine encoding multistage antigens in conjunction with ubiquitin confers protective immunity to BALB/c mice against parasite infection.
Yin H; Zhao L; Wang T; Zhou H; He S; Cong H
Parasit Vectors; 2015 Sep; 8():498. PubMed ID: 26420606
[TBL] [Abstract][Full Text] [Related]
26. Toxoplasma gondii: acquired ocular toxoplasmosis in the murine model, protective role of TNF-alpha and IFN-gamma.
Gazzinelli RT; Brézin A; Li Q; Nussenblatt RB; Chan CC
Exp Parasitol; 1994 Mar; 78(2):217-29. PubMed ID: 8119376
[TBL] [Abstract][Full Text] [Related]
27. Mast cell activator compound 48/40 is not an effective adjuvant for UV-attenuated Toxoplasma gondii vaccine.
Li X; Chen S; Huang S; Lu F
Parasitol Res; 2017 Aug; 116(8):2347-2353. PubMed ID: 28573462
[TBL] [Abstract][Full Text] [Related]
28. IL-17 and IL-22 elicited by a DNA vaccine encoding ROP13 associated with protection against Toxoplasma gondii in BALB/c mice.
Alizadeh P; Ahmadpour E; Daryani A; Kazemi T; Spotin A; Mahami-Oskouei M; Flynn RJ; Azadi Y; Rajabi S; Sandoghchian S
J Cell Physiol; 2019 Jul; 234(7):10782-10788. PubMed ID: 30565688
[TBL] [Abstract][Full Text] [Related]
29. Intact immune defenses are required for mice to resist the ts-4 vaccine strain of Toxoplasma gondii.
Sayles PC; Johnson LL
Infect Immun; 1996 Aug; 64(8):3088-92. PubMed ID: 8757838
[TBL] [Abstract][Full Text] [Related]
30. Immunological evaluation of a DNA cocktail vaccine with co-delivery of calcium phosphate nanoparticles (CaPNs) against the Toxoplasma gondii RH strain in BALB/c mice.
Rahimi MT; Sarvi S; Sharif M; Abediankenari S; Ahmadpour E; Valadan R; Ramandie MF; Hosseini SA; Daryani A
Parasitol Res; 2017 Feb; 116(2):609-616. PubMed ID: 27909791
[TBL] [Abstract][Full Text] [Related]
31. Virus-like Particle Vaccine Containing Toxoplasma gondii Rhoptry Protein 13 Induces Protection against T. gondii ME49 Infection in Mice.
Kang HJ; Chu KB; Lee SH; Kim MJ; Park H; Jin H; Quan FS
Korean J Parasitol; 2019 Oct; 57(5):543-547. PubMed ID: 31715698
[TBL] [Abstract][Full Text] [Related]
32. Both lymphotoxin-alpha and TNF are crucial for control of Toxoplasma gondii in the central nervous system.
Schlüter D; Kwok LY; Lütjen S; Soltek S; Hoffmann S; Körner H; Deckert M
J Immunol; 2003 Jun; 170(12):6172-82. PubMed ID: 12794148
[TBL] [Abstract][Full Text] [Related]
33. Vaccination of mice with the protective F3G3 antigen of Toxoplasma gondii activates CD4+ but not CD8+ T cells and induces Toxoplasma specific IgG antibody.
Brinkmann V; Remington JS; Sharma SD
Mol Immunol; 1993 Mar; 30(4):353-8. PubMed ID: 8096062
[TBL] [Abstract][Full Text] [Related]
34. A role for CD4+ NK1.1+ T lymphocytes as major histocompatibility complex class II independent helper cells in the generation of CD8+ effector function against intracellular infection.
Denkers EY; Scharton-Kersten T; Barbieri S; Caspar P; Sher A
J Exp Med; 1996 Jul; 184(1):131-9. PubMed ID: 8691126
[TBL] [Abstract][Full Text] [Related]
35. [Study on construction and immune protective effect of recombinant nucleic acid vaccine of Toxoplasma gondii].
Wei QK
Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2012 Apr; 24(2):173-7, 182. PubMed ID: 22799162
[TBL] [Abstract][Full Text] [Related]
36. Complete protection against lethal Toxoplasma gondii infection in mice immunized with a plasmid encoding the SAG1 gene.
Nielsen HV; Lauemøller SL; Christiansen L; Buus S; Fomsgaard A; Petersen E
Infect Immun; 1999 Dec; 67(12):6358-63. PubMed ID: 10569750
[TBL] [Abstract][Full Text] [Related]
37. Immune responses and protection after DNA vaccination against Toxoplasma gondii calcium-dependent protein kinase 2 (TgCDPK2).
Chen K; Wang JL; Huang SY; Yang WB; Zhu WN; Zhu XQ
Parasite; 2017; 24():41. PubMed ID: 29119944
[TBL] [Abstract][Full Text] [Related]
38. Protective immunity against acute toxoplasmosis in BALB/c mice induced by a DNA vaccine encoding Toxoplasma gondii 10 kDa excretory-secretory antigen (TgESA10).
Wang S; Wang Y; Sun X; Zhang Z; Liu T; Gadahi JA; Xu L; Yan R; Song X; Li X
Vet Parasitol; 2015 Nov; 214(1-2):40-8. PubMed ID: 26421596
[TBL] [Abstract][Full Text] [Related]
39. A Lactate Fermentation Mutant of
Xia N; Zhou T; Liang X; Ye S; Zhao P; Yang J; Zhou Y; Zhao J; Shen B
Front Immunol; 2018; 9():1814. PubMed ID: 30147689
[No Abstract] [Full Text] [Related]
40. Protective immune response against Toxoplasma gondii elicited by a novel yeast-based vaccine with microneme protein 16.
Wang LJ; Xiao T; Xu C; Li J; Liu GZ; Yin K; Cui Y; Wei QK; Huang BC; Sun H
Vaccine; 2018 Jun; 36(27):3943-3948. PubMed ID: 29793893
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
